Biological therapy of squamous cell cancers of the head and neck
Author:
Dillman Robert O.
Publisher
Springer Netherlands
Reference63 articles.
1. Baselga J, Trigo JM, Bourhis J, et al. Phase II multicenter study of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum-refractory metastatic and/or recurrent squamous cell carcinoma of the head and neck. J Clin Oncol 2005;23:5568–77.
2. Benasso M, Merlano M, Blengio F, et al. Concomitant alpha-interferon and chemotherapy in advanced squamous cell carcinoma of the head and neck. Am J Clin Oncol 1993;16:465–8.
3. Bensmaine ME, Azli N, Domenge C, et al. Phase I-II trial of recombinant interferon alpha-2b with cisplatin and 5-fl uorouracil in recurrent and/or metastatic carcinoma of head and neck. Am J Clin Oncol 1996;19:249–54.
4. Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006;354:567–78.
5. Bourhis J, Rivera F, Mesia R, et al. Phase I/II study of cetuximab in combination with cisplatin or carboplatin and fl uorouracil in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. J Clin Oncol 2006;24:2866–72.